Cetera Investment Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.6K Buy
+4,000
New +$932K ﹤0.01% 4677
2023
Q4
Sell
-100
Closed -$690 2293
2023
Q3
$690 Hold
100
﹤0.01% 2195
2023
Q2
$57 Hold
100
﹤0.01% 2191
2023
Q1
$192 Hold
100
﹤0.01% 2159
2022
Q4
$36 Hold
100
﹤0.01% 2106
2022
Q3
$1K Hold
100
﹤0.01% 1712
2022
Q2
$1K Buy
+100
New +$17.8K ﹤0.01% 1813

Other funds holding JNJ

Cetera Investment Advisers's JNJ Position: Q1 2026 in Review

Cetera Investment Advisers increased its Johnson & Johnson (JNJ) stake by 1% in Q1 2026, buying an estimated $2.48M and bringing the position to 1,034,600 shares worth $253M. The position accounts for 0.27% of the portfolio, ranked #65.

Cetera Investment Advisers first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cetera Investment Advisers held 1,034,600 shares of Johnson & Johnson worth $253M as of Q1 2026.
  • Cetera Investment Advisers bought 10,644 Johnson & Johnson shares in Q1 2026, an estimated $2.48M.
  • Johnson & Johnson made up 0.27% of Cetera Investment Advisers's portfolio in Q1 2026, its #65 holding.
  • Cetera Investment Advisers first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.